Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00400218
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2006-11-15
Brief Title:
Evaluate the Safety and Anti-Hypertensive Efficacy of HyzaarR In Patients With Mild To Moderate Essential Hypertension 0954A-323
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
Evaluate the Safety and Tolerability of HyzaarR Losartan 50 Mg Hydrochlorothiazide 125 Mg In the Treatment of Hypertension
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate the safety and anti-hypertensive efficacy of hyzaarR in patients with mild to moderate essential hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_049 | None | None | None |